Transplant

118 drugs in development·45 companies·2 clinical trials

Drug Pipeline by Phase

Approved(19)

Drug	Company
AMNIOFIX	MiMedx Group Inc (MDXG)
busulfan	Amneal Pharmaceuticals, Inc. (AMRX)
busulfan	NEXUS BIOPHARMA INC (NEXS)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)
fulphila	Mylan II B.V. (MYL)
graftassurecore	Insight Molecular Diagnostics Inc. (IMDX)
lenalidomide	Mylan II B.V. (MYL)
mia fora ngs	IMMUCOR INC (BLUD)
Monjuvi	Xencor Inc (XNCR)
mycophenolate mofetil	Amneal Pharmaceuticals, Inc. (AMRX)
prednisone	DR REDDYS LABORATORIES LTD (RDY)
Prevymis	Merck & Co., Inc. (MRK)
sirolimus	Amneal Pharmaceuticals, Inc. (AMRX)
syncardia tah	Picard Medical Inc. (PMI)
tacrolimus	Mylan II B.V. (MYL)
tacrolimus	NEXUS BIOPHARMA INC (NEXS)
yartemlea	OMEROS CORP (OMER)

Phase 3(25)

Drug	Company
alemtuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
anti-cd20 antibodies	POINT Biopharma Global Inc. (PNT)
anti-cd20 antibodies	GT Biopharma, Inc. (GTBP)
belatacept	Cidara Therapeutics, Inc. (CDTX)
belatacept	ENANTA PHARMACEUTICALS INC (ENTA)
belumosudil	Sanofi (SNY)
Belumosudil	Sanofi (SNY)
eculizumab	POINT Biopharma Global Inc. (PNT)
eculizumab	GT Biopharma, Inc. (GTBP)
frexalimab	Sanofi (SNY)
graftassuredx	Insight Molecular Diagnostics Inc. (IMDX)
ivig	POINT Biopharma Global Inc. (PNT)
ivig	GT Biopharma, Inc. (GTBP)
Liposomal Cyclosporine A	Crinetics Pharmaceuticals, Inc. (CRNX)
nomacopan	Akari Therapeutics Plc (AKTX)
Peripheral blood stem cells	Filana Therapeutics Inc. (FLNA)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
ROVALCYTE	Crinetics Pharmaceuticals, Inc. (CRNX)
Sirolimus	Filana Therapeutics Inc. (FLNA)
Tab-cel (Ebvallo)	Atara Biotherapeutics, Inc. (ATRA)
tabelecleucel	Atara Biotherapeutics, Inc. (ATRA)
Tacrolimus	Filana Therapeutics Inc. (FLNA)
Tacrolimus	Sanofi (SNY)
Temsirolimus	Filana Therapeutics Inc. (FLNA)
Unrelated donor bone marrow transplant	Filana Therapeutics Inc. (FLNA)

Phase 2(29)

Drug	Company
antithymocyte globulin	Sanofi (SNY)
Arm 1	Coya Therapeutics, Inc. (COYA)
Arm 2A	Coya Therapeutics, Inc. (COYA)
Arm 2B	Coya Therapeutics, Inc. (COYA)
at-1501	Eledon Pharmaceuticals, Inc. (ELDN)
Bortezomib	Coeptis Therapeutics Holdings Inc. (COEP)
bti-410	NANOMIX CORP (BTHI)
Busulfan	Filana Therapeutics Inc. (FLNA)
cfz533 - cohort 1/cohort 2	NOVARTIS AG (NVSEF)
cfz533 - cohort 1/cohort 2	Novartis AG (NVS)
clazakizumab	ALDER BIOPHARMACEUTICALS INC (ALDR)
Daratumumab	Coeptis Therapeutics Holdings Inc. (COEP)
Frexalimab	Sanofi (SNY)
G-CSF	PTC THERAPEUTICS, INC. (PTCT)
GPC-100	PTC THERAPEUTICS, INC. (PTCT)
Haploidentical donor bone marrow transplant	Filana Therapeutics Inc. (FLNA)
inactivated non adjuvanted pandemic H1N1 vaccine	Cidara Therapeutics, Inc. (CDTX)
induction therapy	Novartis AG (NVS)
intravenous immunoglobulin	Sanofi (SNY)
intravenous immunoglobulin	Sanofi (SNYNF)
maintenance population	Novartis AG (NVS)
maintenance population	NOVARTIS AG (NVSEF)
MiMedx AmnioFix	MiMedx Group Inc (MDXG)
narsoplimab	OMEROS CORP (OMER)
nexi-001	NexImmune, Inc. (NEXI)
Propranolol	PTC THERAPEUTICS, INC. (PTCT)
Tafasitamab	ENANTA PHARMACEUTICALS INC (ENTA)
tff tac	TFF PHARMACEUTICALS, INC. (TFFP)
vib4920	Viela Bio, Inc. (VIE)

Phase 1(22)

Drug	Company
alemtuzumab	Accustem Sciences Inc. (ACUT)
alemtuzumab	Cidara Therapeutics, Inc. (CDTX)
Alemtuzumab	Filana Therapeutics Inc. (FLNA)
belatacept	Accustem Sciences Inc. (ACUT)
bivv020	Sanofi (SNY)
bivv020	Sanofi (SNYNF)
carfilzomib	ENANTA PHARMACEUTICALS INC (ENTA)
carfilzomib	Cidara Therapeutics, Inc. (CDTX)
Donor-derived Mesenchymal Stromal Cells	Cidara Therapeutics, Inc. (CDTX)
Donor-derived Mesenchymal Stromal Cells	Accustem Sciences Inc. (ACUT)
fostamatinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Megadose Drug Combination	Cell Source, Inc. (CLCS)
mycophenolate acid	Accustem Sciences Inc. (ACUT)
mycophenolate mofetil	ENANTA PHARMACEUTICALS INC (ENTA)
mycophenolate mofetil	Cidara Therapeutics, Inc. (CDTX)
mycophenolate mofetil	Accustem Sciences Inc. (ACUT)
plx-r18	Pluri Inc. (PLUR)
QEL-001	Coya Therapeutics, Inc. (COYA)
sirolimus	Cidara Therapeutics, Inc. (CDTX)
sirolimus	Accustem Sciences Inc. (ACUT)
TAK-079	Merus N.V. (MRUS)
Veto Cell	Cell Source, Inc. (CLCS)

Preclinical(9)

Drug	Company
abi-7272	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-7423 (7423)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
Anti-Rejection Anti-Viral Veto Cell	Cell Source, Inc. (CLCS)
fsi-174	Forty Seven, Inc. (FTSV)
fsi-189	Forty Seven, Inc. (FTSV)
graftassureiq	Insight Molecular Diagnostics Inc. (IMDX)
Non-nucleoside polymerase inhibitor (NNPI program)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
nulife process	NULIFE SCIENCES, INC. (NULF)
Veto Cell technology	Cell Source, Inc. (CLCS)

Unknown(1)

Drug	Company
Public cord blood units (public banking)	Cryo-Cell International Inc. (CCEL)

Phase 1/Phase 2(1)

Drug	Company
syn-004	Theriva Biologics, Inc. (TOVX)

Phase 2/Phase 3(8)

Drug	Company
antithymocyte globulin	Sanofi (SNY)
Iomab-B	Actinium Pharmaceuticals, Inc. (ATNM)
mycophenolate	Sanofi (SNY)
mycophenolate	Sanofi (SNY)
mycophenolate mofetil	Sanofi (SNY)
mycophenolate sodium	Sanofi (SNY)
rabbit anti-thymocyte globulin	Sanofi (SNY)
rabbit anti-thymocyte globulin	Sanofi (SNYNF)

Phase 4(4)

Drug	Company
Azithromycin	Sanofi (SNY)
Belumosudil mesylate	Sanofi (SNY)
plerixafor + g-csf	Sanofi (SNY)
Single Dose Liposomal Bupivicaine	Crinetics Pharmaceuticals, Inc. (CRNX)

BioSniper tracks 118 drugs in development for Transplant across 45 companies.

There are 2 clinical trials targeting Transplant tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.